SPRINGFIELD, Ill. – The Illinois Department of Public Health (IDPH) has approved four new conditions for treatment with medicinal cannabis, a first in six years. Approved under Illinois law following ...

Silo Pharma (NASDAQ: SILO) received a Notice of Allowance from the U.S. Patent and Trademark Office for a key patent supporting its lead asset, SPC- ...

A holistic approach to managing chronic pain focuses on addressing the root cause of discomfort rather than simply masking pain. Join the Peak's email list for the top headlines right in your inbox ...

Learn where to buy the best kratom powder from reliable sellers with quality products and customer service. Find out why ...

The patent, when formally approved, will reinforce protection for Silo’s lead asset, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The patent includes newly added ...

Mr. Ainsworth brings over two decades of industry and market access experience to Tonix U.S. Food and Drug Administration ...

Incident use of gabapentin is not associated with an increase in fall-related hospital visits compared with duloxetine ...

Coping with fibromyalgia as a parent can feel overwhelming, but avoiding common pitfalls makes a big difference. In this ...

A recent systematic review published in the Journal of American Medical Association revealed that stricter opioid prescribing ...

Customer Care Beachcomber Hot Tubs + 1-866-389-7878 email us here Visit us on social media: Facebook X Instagram YouTube Other ...

For people suffering from chronic knee pain, especially those over 50, a new treatment is offering hope and relief.

IND submission for intranasal SPC-15 treatment expected in 2025; Phase 1 clinical trial to follow upon approvalSP-26 ketamine implants nearing ...